Overview

Persistent AF ablation demands precision, lesion integrity, and an efficient workflow. This expert-led webinar brings together leading electrophysiologists to share the latest innovations, clincial evidence, and real-world strategies driving better outcomes.

Prof Serge Boveda will set the scene with Setting the Stage: Innovations and Insights in AF Ablation, before unveiling key results from ADVANTAGE AF Phase I & II: Safety, Efficacy, and Beyond. Prof Daniel Scherr will take you inside a recorded case, Persistent AF and PWA Strategy: From Mapping to Optimisation, demonstrating how FARAVIEW™ supports lesion delivery mastery in the clinical workflow. Prof Christian Sohns will then spotlight Rethinking Lesion Depth: A New Frontier in Focal Ablation Technology.

The session closes with The Final Pulse: Debating Clinical Decisions in Persistent AF,  a dynamic Q&A where faculty will tackle your most pressing questions.

Don’t miss this opportunity to enhance your approach to persistent AF ablation and gain actionable insights from world-class experts.

EP-2268204-AA

FARAPOINT™ PFA Catheter is pending CE mark. Not available for sales. 

FARAPULSE™ PFA Platform - CE 0459. Use of FARAPULSE™ for treatment of Persistent AF is pending CE Mark.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France. ©2025 Boston Scientific Corporation or its affiliates. All rights reserved.